Itamar Medical Ltd. (ITMR): Price and Financial Metrics


Itamar Medical Ltd. (ITMR): $21.60

0.16 (+0.75%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ITMR POWR Grades


  • ITMR scores best on the Sentiment dimension, with a Sentiment rank ahead of 91.12% of US stocks.
  • The strongest trend for ITMR is in Sentiment, which has been heading up over the past 31 weeks.
  • ITMR ranks lowest in Quality; there it ranks in the 5th percentile.

ITMR Stock Summary

  • ITMR's went public 2.28 years ago, making it older than only 5.12% of listed US stocks we're tracking.
  • Over the past twelve months, ITMR has reported earnings growth of 2,760.54%, putting it ahead of 99.28% of US stocks in our set.
  • Revenue growth over the past 12 months for Itamar Medical Ltd comes in at 98.22%, a number that bests 93.98% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Itamar Medical Ltd are ITRN, ERF, ORI, GRVY, and MX.
  • Visit ITMR's SEC page to see the company's official filings. To visit the company's web site, go to www.itamar-medical.com.

ITMR Stock Price Chart Interactive Chart >

Price chart for ITMR

ITMR Price/Volume Stats

Current price $21.60 52-week high $29.00
Prev. close $21.44 52-week low $17.18
Day low $20.99 Volume 92,200
Day high $21.60 Avg. volume 42,366
50-day MA $22.04 Dividend yield N/A
200-day MA $21.96 Market Cap 347.93M

Itamar Medical Ltd. (ITMR) Company Bio


Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.


ITMR Latest News Stream


Event/Time News Detail
Loading, please wait...

ITMR Latest Social Stream


Loading social stream, please wait...

View Full ITMR Social Stream

Latest ITMR News From Around the Web

Below are the latest news stories about Itamar Medical Ltd that investors may wish to consider to help them evaluate ITMR as an investment opportunity.

Itamar Medical Launches Enhancements to WatchPAT™ Product Line at SLEEP 2021

Enables Patient Smartphone App to Collect Subjective Data at Time of Test Designed to Improve the Quality and Efficiency of Home Sleep Diagnostics CAESAREA, Israel, June 07, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced two enhancements to its WatchPAT™ product line that the Company plans to unveil on June 11 durin

Yahoo | June 7, 2021

Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q1 2021 Results - Earnings Call Transcript

Itamar Medical Ltd. (ITMR) Q1 2021 Earnings Conference Call May 19, 2021, 08:00 AM ET Company Participants Leigh Salvo - IR Gilad Glick - CEO Shy Basson - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Josh Jennings - Cowen Richard Newitter - SVB Leerink Jeffrey Cohen - Ladenburg...

SA Transcripts on Seeking Alpha | May 20, 2021

Itamar Medical EPADS beats by $0.01, beats on revenue

Itamar Medical (ITMR): Q1 Non-GAAP EPADS of -$0.20 beats by $0.01; GAAP EPADS of -$0.36 misses by $0.15.Revenue of $12M (+43.2% Y/Y) beats by $0.88M.Press Release...

Seeking Alpha | May 19, 2021

Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Wednesday, May 19, 2021

CAESAREA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results for the first quarter 2021 before the U.S. market opens on Wednesday, May 19, 2021. The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial results and provide a corporate update. The call will be hosted by Gilad Glick, President and CEO, and Shy Basson, CFO. To listen live via webcast, please visit https://edge.media-server.com/mmc/p/vemth6m6. To participate via phone, please use the following dial in information:U.S. toll-free: 1-8...

Yahoo | May 5, 2021

Itamar Medical Provides Highlights of Recent Survey in Sleep Test Market

Significant Majority Expect Home Sleep Apnea Test Usage to Expand and in-lab Usage to Decline Most Clinicians Expect More than Half of Future Sleep Diagnostics Will Be At-Home Tests Results Indicate Vast Majority of Participants Use HSAT in Their Practices Today CAESAREA, Israel, April 12, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced results from a recent survey to health care professionals that covered sleep testing dynamics in their practices during 2020 and expectations for future use of Home Sleep Apnea Testing (HSAT) versus Polysomnography (PSG) testing performed in sleep laboratories. Key findings o...

Yahoo | April 12, 2021

Read More 'ITMR' Stories Here

ITMR Price Returns

1-mo 2.03%
3-mo -5.26%
6-mo 20.00%
1-year -0.23%
3-year N/A
5-year N/A
YTD 8.76%
2020 54.31%
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8205 seconds.